Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > pssssst

<< Previous

Bullboard Posts

Next >>

Comment by canadafanon Nov 25, 2020 4:16pm

263 Views

Post# 31972414

RE:RE:RE:RE:RE:pssssst

ratsnake220, you have no idea what you are talkng about.

Please spend some time and look up ONC web site, read the invetsor report and take note of their clinical co-dvelopment trials.
Pfizer, Roche, BMS, Merck & Incyte..all of which have on-going trials and "arrangements" with ONC.
Perhpas you can call anyone of the PHds with your amzing con-game news.
I wellcome negative comments from anyone, but yours are a step bellow writting on washroom wall.
In about 2 weeks, ONC has 3 sponsor trials reports coming due at a global cancer symposium.
Maybe you could show up there or log In and infom the dozzens of world leading cancer specialtsts
about this con-game?

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario